Miyamura K, Osada H, Yamauchi T, Itoh M, Kodera Y, Suchi T, Takahashi T, Ueda R
Department of Internal Medicine, Japanese Red Cross Nagoya First Hospital.
Cancer. 1990 Jul 1;66(1):140-4. doi: 10.1002/1097-0142(19900701)66:1<140::aid-cncr2820660125>3.0.co;2-i.
A 71-year-old man was found to have chronic lymphocytic leukemia (CLL) and diffuse large cell lymphoma (DLC) simultaneously and was diagnosed as Richter's syndrome. The CLL had mu lambda surface immunoglobulin (sIg) whereas the DLC had mu kappa sIg. However, the immunoglobulin (Ig) gene rearrangement and surface marker analysis demonstrated that both CLL and DLC had identical rearrangement patterns of the Ig heavy chain (IgH) and identical surface markers CD5+, CD19+, and CD20+. These facts imply that in this case the two malignancies are of single clonal origin initially, and that different sIg of CLL and DLC do not, therefore, necessarily indicate the biclonality of these malignancies. The origin of DLC in Richter's syndrome remains controversial. This case suggests difficulty in concluding the biclonality of these malignancies. For a conclusion on clonality to be definitive, there is a need for cloning and nucleotide sequencing of rearranged Ig genes in more patients with Richter's syndrome.
一名71岁男性被发现同时患有慢性淋巴细胞白血病(CLL)和弥漫性大细胞淋巴瘤(DLC),并被诊断为 Richter 综合征。CLL 具有 μλ 表面免疫球蛋白(sIg),而 DLC 具有 μκ sIg。然而,免疫球蛋白(Ig)基因重排和表面标志物分析表明,CLL 和 DLC 具有相同的 Ig 重链(IgH)重排模式以及相同的表面标志物 CD5+、CD19+ 和 CD20+。这些事实表明,在该病例中,这两种恶性肿瘤最初起源于单一克隆,因此 CLL 和 DLC 不同的 sIg 不一定表明这些恶性肿瘤具有双克隆性。Richter 综合征中 DLC 的起源仍存在争议。该病例提示难以确定这些恶性肿瘤的双克隆性。为了明确克隆性结论,需要对更多 Richter 综合征患者的重排 Ig 基因进行克隆和核苷酸测序。